CONCORDBIONSEConcord Biotech Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 8 Dec, 2025 · 13:58 IST

Concord Biotech CFO to retire early effective Jan 5, 2026

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

CONCORDBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.3%Reaction day
₹1409.00
prior close
₹1357.90
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-2.3%-1.0% vs market
Pharmaceuticals peers, median of 156sector-2.0%-1.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Smallcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.1
15m
+0.0
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.3-2.3-1.0-2.0-1.3
Next day
-2.4-1.3-1.1-1.3-1.1
2d
-2.1-2.0-0.1-1.4-0.7
3d
-2.7-1.4-1.3-1.0-1.7
4d
-2.4-0.6-1.8-0.8-1.6
5d
-3.5-0.2-3.2-0.5-3.0
1w
-5.7-1.7-4.0-2.1-3.6
15d
-4.9-0.0-4.9-2.0-2.9
1m
-4.5-0.0-4.5-0.8-3.8
2m
-10.0-1.4-8.7-5.0-5.0
3m
-16.9-8.7-8.2-10.8-6.1
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr Lalit Sethi, Chief Financial Officer and Key Managerial Personnel of Concord Biotech, has informed about his early retirement due to personal reasons including family commitments and health, effective close of business hours on January 5, 2026. The trading window for dealing in company securities has been closed from December 8, 2025. He has committed to a seamless handover of financials, compliance and investor relations materials.

Likely market impact

CFO exit may cause near term uncertainty. Smooth transition assured; investors will watch for successor appointment announcement.